Oxford, United Kingdom

Jac Wijkmans

This inventor holds 1 USPTO granted patent. Top assignee: De Novo Pharmaceuticals Limited. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jac Wijkmans. Retrieved from https://idiyas.com/inventor/jac-wijkmans

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jac Wijkmans: Innovator in Antimicrobial Agents

Introduction

Jac Wijkmans is a notable inventor based in Oxford, GB. He has made significant contributions to the field of antimicrobial agents, showcasing his expertise through his innovative patent.

Latest Patents

Wijkmans holds a patent for antimicrobial agents, specifically compounds of formula (I) and (IA) that exhibit antibacterial or antiprotozoal activity. The patent details complex chemical structures, including radicals and linkages that contribute to the efficacy of these compounds.

Career Highlights

Wijkmans is associated with De Novo Pharmaceuticals Limited, where he applies his knowledge and skills in the development of new pharmaceutical solutions. His work focuses on creating effective antimicrobial agents that can combat various infections.

Collaborations

Throughout his career, Wijkmans has collaborated with esteemed colleagues such as Barry Porter and Paul Gane. These partnerships have enhanced his research and development efforts in the pharmaceutical industry.

Conclusion

Jac Wijkmans is a distinguished inventor whose work in antimicrobial agents has the potential to make a significant impact in healthcare. His innovative approach and collaboration with other experts highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…